Human nicotinic acetylcholine receptor (AChR) subtypes ␣32, ␣32␣5, ␣34, and ␣34␣5 were stably expressed in cells derived from the human embryonic kidney cell line 293. ␣34 AChRs were found in prominent 2-m patches on the cell surface, whereas most ␣32 AChRs were more diffusely distributed. The functional properties of the ␣3 AChRs in tsA201 cells were characterized by whole cell patch clamp using both acetylcholine and nicotine as agonists. Nicotine was a partial agonist on ␣34 AChRs and nearly a full agonist on ␣32␣5 AChRs. Chronic exposure of cells expressing ␣32 AChRs or ␣32␣5 AChRs to nicotine or carbamylcholine increased their amount up to 24-fold but had no effect on the amount of ␣34 or ␣34␣5 AChRs, i.e. the up-regulation of ␣3 AChRs depended on the presence of 2 but not 4 subunits in the AChRs. This was also found to be true of ␣3 AChRs in the human neuroblastoma SH-SY5Y. In the absence of nicotine, ␣32 AChRs were expressed at much lower levels than ␣34 AChRs, but in the presence of nicotine, the amount of ␣32 AChRs exceeded that of ␣34 AChRs. Up-regulation was seen for both total AChRs and surface AChRs. Up-regulated ␣32 AChRs were functional. The nicotinic antagonists curare and dihydro--erythroidine also up-regulated ␣32 AChRs, but only by 3-5-fold. The channel blocker mecamylamine did not cause up-regulation of ␣32 AChRs and inhibited up-regulation by nicotine. Our data suggest that up-regulation of ␣32 AChRs in these lines by nicotine results from both increased subunit assembly and decreased AChR turnover.